Using established FACS protocols for the detection of EPCs and SMPCs we observed that the frequency of circulating CD34+ and CD34+KDR+ cells is reduced in patients with diabetes, whereas the levels of CD14+CD105+ SMPCs are not significantly changed by the presence of diabetes. This evidence concerns the gene CD14 and diabetes mellitus.